The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > GenVec, Inc.

GenVec, Inc.
Nasdaq: GNVC
Change
symbol:
     
 PROFILE
GenVec can make a human heart swell -- with blood. The firm's lead product candidate, BIOBYPASS angiogen, is a gene therapy that may induce new blood vessel formation (angiogenesis) in hearts. BIOBYPASS would be an alternative to angioplasty or bypass surgery. GenVec has teamed with Warner-Lambert, a unit of Pfizer, to develop and market the therapy. The company's GENSTENT may prevent the narrowing of blood vessels damaged by angioplasty or blood vessel grafts by accelerating healing at the surgical site. GenVec is also working on products to combat cancer and the excess growth of abnormal blood vessels in the eye, a leading cause of blindness.

 COMPETITION
Collateral Therapeutics, Inc. (CLTX)
EntreMed, Inc. (ENMD)
IRIDEX Corporation (IRIX)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 13.90
1-Yr. Sales Growth: (17.8)%
Employees: 84
Revenue per employee: $165,476.19

 KEY PEOPLE
• Paul H. Fischer
    CEO
• Jeffrey W. Church
    CFO

 CONTACT INFO
65 W. Watkins Mill Rd.
Gaithersburg, MD 20878
US
Phone: 240-632-0740
Fax: 240-632-0735
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001